Two Men Admit to Drug Trafficking
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • Two Men Admit to Drug Trafficking

Two Men Admit to Drug Trafficking

Octubre 28, 2022
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Kenneth M. Heino
Phone Number: (571) 362-6616

CAMDEN, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a Philadelphia man today admitted trafficking in large quantities of methamphetamine and fentanyl in southern New Jersey and Philadelphia, and a New Jersey man admitted to possessing with intent to distribute methamphetamine.

Kevin Salmon, 25, of Philadelphia, and John Munson, 47, of Deptford, New Jersey, each pleaded guilty before U.S. District Judge Noel L. Hillman in Camden federal court. Salmon pleaded guilty to two counts of a superseding indictment charging him with conspiring to distribute fentanyl and methamphetamine and distributing methamphetamine. Munson pleaded guilty to one count of the superseding indictment charging him with possessing with intent to distribute methamphetamine.

Salmon acted as a “runner” or “courier” for a drug-trafficking organization that distributed large quantities of methamphetamine and fentanyl. He would distribute these drugs to others. Salmon also admitted possessing two operable firearms at his residence while storing in the same location more than 2,500 grams of methamphetamine for the conspiracy. Munson admitted obtaining methamphetamine from the conspiracy in order to distribute the methamphetamine to others.

Two defendants – Glenn Long and Savon Skipwith – remain charged in the same superseding indictment and are scheduled for trial in February 2023. The charges against them are merely accusations, and they are presumed innocent unless and until proven guilty. Ten other defendants have previously pleaded guilty as a result of the investigation.

Salmon faces a mandatory minimum of 10 years in prison and a maximum of life in prison and a $10 million fine. Munson faces a mandatory minimum of five years in prison, a maximum of 40 years in prison and a $5 million fine. Sentencing for both defendants is scheduled for March 9, 2023.

U.S. Attorney Sellinger credited special agents with the Drug Enforcement Administration, New Jersey Division, under the direction of Special Agent in Charge Susan A. Gibson, with the investigation leading to today’s pleas. He also thanked the U.S. Attorney’s Office for the Eastern District of Pennsylvania; Drug Enforcement Administration, Philadelphia Division; U.S. Department of Homeland Security – Homeland Security Investigations; U.S. Marshals Service; FBI; Bensalem Police Department; Berlin Borough Police Department; Berlin Township Police Department; Bucks County District Attorney’s Office; Camden County Prosecutor’s Office; Clayton Police Department; Delaware County District Attorney’s Office Narcotics Task Force; Deptford Township Police Department; Gloucester County Prosecutor’s Office; Gloucester Township Police Department; New Jersey State Police; New Jersey National Guard Counter Drug Task Force; Pennsylvania State Police; Pennsville Police Department; and Winslow Township Police Department for their assistance.

22-31

Download Press Release
###
Methamphetamine Fentanyl
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Towanda Thorne-James Special Agent in Charge - New Jersey
@DEANewJerseyDiv
  • Facebook
  • X
  • Email
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster